Effect of Neurological Issues on COVID Mortality
People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients, according researchers at Montefiore Health System and Albert Einstein College of Medicine in the journal
These findings have the potential to identify and focus treatment efforts on individuals most at risk and could decrease COVID-19 deaths, a media release from Albert Einstein College of Medicine suggests.
The study looked at data from 4,711 COVID-19 patients who were admitted to Montefiore during the 6-week period between March 1, 2020 and April 16, 2020. Of those patients, 581 (12%) had neurological problems serious enough to warrant brain imaging. These individuals were compared with 1,743 non-neurological COVID-19 patients of similar age and disease severity who were admitted during the same period.
The U.S. new cases 7-day rolling average are 1.3 % HIGHER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 5.6 %
HIGHER than the rolling average one week ago. U.S. deaths due to coronavirus are now 9.4 %
HIGHER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are at an elevated 196,295
U.S. Coronavirus deaths are at an elevated 2,571
U.S. Coronavirus hospitalizations are at an elevated 113,929
The 7-day rolling average rate of growth of the pandemic shows new cases improved, hospitalizations improved, and deaths worsened
Like much about the virus, exactly how much Thanksgiving gatherings spread it and why the effects seem to have varied so much from place to place remains unclear.
Stroke and altered mental state increase risk of death for COVID-19 patients medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
E-Mail
December 18, 2020 (BRONX, NY) People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients, according to a study published online today by researchers at Montefiore Health System and Albert Einstein College of Medicine in the journal
Neurology®, the medical journal of the American Academy of Neurology. These findings have the potential to identify and focus treatment efforts on individuals most at risk and could decrease COVID-19 deaths.
The study looked at data from 4,711 COVID-19 patients who were admitted to Montefiore during the six-week period between March 1, 2020 and April 16, 2020. Of those patients, 581 (12%) had neurological problems serious enough to warrant brain imaging. These individuals were compared with 1,743 non-neurological COVID-19 patients of similar age and disease severity who were admitted during the same period.